Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Brain And Spinal Cord Tumours

Cancer Research UK and immatics biotechnologies launch trial for brain cancer

Cancer Research UK and Cancer Research Technology with immatics biotechnologies have launched the first trial of a promising cancer vaccine.

Gene therapy could 'train' immune system to destroy brain cancer cells

Scientists are developing a new gene therapy approach that 'trains' the immune system to destroy brain cancer cells and restore normal brain function.

Scientists uncover basis for drug resistance in common childhood cancer

US scientists say they have worked out why acute lymphoblastic leukaemia can come back after treatment.

Childhood brain cancer may be caused by infection

Cancer Research UK scientists have found evidence that children's brain cancers could be caused by infection with bacteria or a virus.

Deaths from cancer in children fall by almost 60 per cent since the '60s

THE RATE of children dying from cancer has fallen by almost 60 per cent over the last 40 years, according to new figures from Cancer Research UK.

Brain tumours may need multiple drug treatment

Researchers have found that brain tumours often have more than one overactive cell-growth 'switch.'

Scientists divide ependymoma brain tumours into two types

Researchers have discovered that a brain tumour that affects both children and adults can be divided into two clinically distinct groups.

Cancer Research UK and immatics Biotechnologies to trial vaccine for brain cancer

Cancer Research UK and Cancer Research Technology have reached a collaboration agreement with immatics Biotechnologies to trial their new vaccine.

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

No link between mobile phones and brain tumour, says study

There is no evidence to suggest that mobile phone usage increases the risk of glioma, according to results of a study published by the BMJ.